Harry A. George serves as Executive at HTG MOLECULAR DIAGNOSTICS, INC, where they oversee executive responsibilities. Since joining the company, Harry A. George has executed 10 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 14, 2019 involved receiving (via award) 2,500 shares valued at $0.
Harry A. George currently holds 39,030 shares of HTG MOLECULAR DIAGNOSTICS, INC (HTGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Harry A. George has been a net neutral trader of HTGM stock. They have purchased $0 and sold $0 worth of shares.
Harry A. George's most recent insider trade was on Aug 14, 2019, when they sold 2,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 29, 2017 | HTGM | $8.6K | Award | 4,030 | $2.14 | Discretionary |
| Nov 28, 2017 | HTGM | $16.4K | Award | 7,500 | $2.19 | Discretionary |
| Nov 27, 2017 | HTGM | $16.6K | Award | 7,500 | $2.21 | Discretionary |
| Nov 24, 2017 | HTGM | $16.5K | Award | 7,500 | $2.20 | Discretionary |
| Nov 22, 2017 | HTGM | $16.9K | Award | 7,500 | $2.25 | Discretionary |
| May 11, 2015 | HTGM | $0 | Conversion | 1,178 | $N/A | Discretionary |
| May 11, 2015 | HTGM | $0 | Conversion | 17,321 | $N/A | Discretionary |
| May 11, 2015 | HTGM | $0 | Conversion | 21,180 | $N/A | Discretionary |